(S)-2-Amino-3-(pyridazin-3-yl)propanoic acid hydrochloride, 95.0%, 250mg

tert-butyl (3S,4S)-4-methyl-3-(methylamino)piperidine-1-carboxylate hemioxalate, 250mg

L(+)-Nipecotic acid, 97.0%, 25g

5-Bromoquinolin-3-ol, 95%, 100mg

(4-Bromo-3-fluorophenyl)methanol, 95.0%, 5g

Methyl 4-chloro-3-(trifluoromethoxy)benzoate, 95%, 1g

Pentadecane>99.0%(GC)100mL

HEPES, 2,5 kg

2-Bromo-4-chloro pyridine, 99.00%, 10g

GC-Kapillarsäule ROTI®Cap-5 MS, unpolar, L 60 m, Ø-Innen 0,25 mm, Filmd. 0,50 µm, 1 Stück

Tert-butyl 3-(cyanomethyl)-3-hydroxyazetidine-1-carboxylate, 98%, 1g

5-(6-methylpyridin-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 2.5g

5'-(4-Aminophenyl)-2',4',6'-trimethyl-[1,1':3',1''-terphenyl]-4,4''-diamine, 95%, 250mg